COLOMBIA – The COVID-19 pandemic has put Latin America’s biotech sector under extreme pressure and highlighted flaws in the ecosystem throughout the region, not the least of which is a lack of viable networks to facilitate cooperation.
SAO PAULO, Brazil – Pharmacovigilance is emerging as a key concern for the development and distribution of biosimilars in Latin America. Experts gathered this week for the BIO Latin America conference focused on the issue and highlighted what they see as a key concern, one that is holding back the spread of that new class of drugs throughout the region.
SAO PAULO, Brazil – Latin America is following the lead of other developed markets by ramping up its focus on personalized medicine, but there are challenges, including the higher costs of those medicines and a lack of regulations.